TIBER CREEK GROUP

Lobbying for PHRMA

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $110,000.00 income · posted Apr 18, 2026

Lobbying activity 3

Medicare/Medicaid

Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Pricing Reform.

Trade (domestic/foreign)

Issues related to intellectual property protections; Issues related to tariffs.

Health Issues

Issues related to the 340B Program - Public Health Service Act (PL 78-410); Issues related to immunization policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.